Redemption Square in Generation Park will feature high-tech parking solution pilot program. Photo via generationpark.com

Houston real estate company McCord Development will roll out an innovative 12-week pilot to learn how to make parking smarter at its master planned development Generation Park in Northeast Houston.

In partnership with Milwaukee-based CivicSmart Inc., a leader in Smart City parking, the company will test a new Internet-of-Things-based parking solution at Generation Park's mixed-use lifestyle center, Redemption Square. The program is only the second of its kind in the U.S., according to McCord.

McCord will install 30 of CivicSmart's solar powered bollards at Redemption Square that track real-time parking occupancy data through LTE license-plate-reading cameras. The data will be analyzed to help McCord optimize traffic and develop better strategies and parking rates.

"We are thrilled to introduce one of the first parking pilot programs in the country,” Ashwin Chandran, Director of Technology Innovation at McCord, said in a statement. “At McCord, we strive to measure and understand behavior in order to enhance the human experience and make efficient business decisions. We hope to use this data to improve the overall performance of our operations across all our assets.”

According to the statement, the intention of the program is to help keep curbside spots available for short-term guests.

From the customer perspective, parkers will pay via text or QR code, where they will enter their license plate number and payment information, which will be stored for subsequent visits.

The bollards can also dispatch up-to-the-minute pricing details to parkers, and can be controlled remotely by the developer to close certain parking spots for special events.

In addition to the 30 bollards, Redemption Square will still also offer free parking in its nearby garage, and other parking options on Redemption Square Road and metered spaces on Assay Street, according to the statement.

Last week, McCord also announced plans to create a 45-acre biomanufacturing campus within the 4,300-acre Generation Park development. Known as BioHub Two, the center will include 500,000 square feet for manufacturing, lab, and office space. It's slated to join San Jacinto College’s Biotech Training Center in the development, which was announced last December.

Other plans for Generation Park include two multifamily complexes, a mixed-use development called The Commons, and retail and green spaces.

McCord will install 30 of CivicSmart's solar powered bollards at Redemption Square that track real-time parking occupancy data through LTE license-plate-reading cameras. Photo courtesy of Generation Park

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.